Effect of buffer pH, buffer concentration and skin with or without enzyme inhibitors on the stability of [Arg 8]-vasopressin

The stability of [Arg 8]-vasopressin (AVP) as a function of buffer pH, buffer concentration, salt concentration, temperature, and skin with and without enzyme inhibitors was investigated. AVP was analyzed by reverse-phase high-performance liquid chromatography. The results indicated that the buffer’...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2000-03, Vol.197 (1), p.87-93
Hauptverfasser: Bi, Mingda, Singh, Jagdish
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The stability of [Arg 8]-vasopressin (AVP) as a function of buffer pH, buffer concentration, salt concentration, temperature, and skin with and without enzyme inhibitors was investigated. AVP was analyzed by reverse-phase high-performance liquid chromatography. The results indicated that the buffer’s pH affected the degradation rate of AVP. Buffer ions (H 2PO 4 − and HPO 4 2−) and salt concentrations had no effect on the degradation of AVP. Maximum stability was achieved at pH 3.35 among pH values tested. The activation energy for the overall reaction was 21.5 kcal mol −1 at pH 3.35. From the Arrhenius equation, the shelf-life of AVP at 25°C and pH 3.35 was calculated to be 1.38 years. The degradation rate of AVP in the skin (area: 9 cm 2, thickness: 0.5 mm) was 0.22 h −1. Bestatin (an aminopeptidase inhibitor) had the best stabilizing effect on the degradation of AVP by skin among the three enzyme inhibitors (i.e. aprotinin, bestatin, and leupeptin) studied. The degradation rate of AVP in the skin was reduced to 0.059 h −1 in the presence of bestatin in comparison with no inhibitor (0.22 h −1).
ISSN:0378-5173
1873-3476
DOI:10.1016/S0378-5173(99)00459-7